Lupin launches generic AptiomEslicarbazepine acetate tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older. IQVIA Institute releases Understanding the Use of Medicines in the U.S. 2025 reportThis year’s report examines how evolving standards of care, new therapies and benefit design are shaping patient access, out-of-pocket costs and overall medicine use. Unjust pharmacy deserts With drug stores closing in record numbers, 45 million Americans are living in pharmacy deserts. Pharma AI Council launches PAC is dedicated to shaping the future of AI in the pharmaceutical, biotech and medical device sectors. Strides Pharma Global obtains FDA OK for generic Celebrex Celecoxib is a selective COX-2 inhibitor used for the management of pain and inflammation associated with various conditions. Camber launches eslicarbazepine acetate tablets Eslicarbazepine acetate tablets are indicated for the treatment of partial-onset seizures in patients aged 4 years of age and older. Alembic debuts generic Brilinta Tricagrelor tablets are indicated to reduce the risk of cardiovascular death, myocardial infarction and stroke. Biocon Biologics secures market access coverage for Stelara biosimilar The market access agreements from numerous plans represent more than 100+ million lives in the United States. NACDS commends Virginia Gov. Glenn Youngkin, lawmakers for move to Single PBM The Save Our Pharmacies Act delivers new transparency and access for Virginia Medicaid patients. Ritedose secures FDA nod for formoterol fumarate inhalation solution Formoterol fumarate inhalation solution is used to treat COPD. 1 2 3 4 5 Next Last
